Prognostic significance of ventricular function and late gadolinium enhancement on CMR in symptomatic patients with scleroderma

Prognostic significance of ventricular function and late gadolinium enhancement on CMR in symptomatic patients with scleroderma

Bibliographic Details
Main Authors:	Natarajan Arun, Dobarro David, Raphael Claire E, Baksi Arun J, Kindler Heiko, Mohiaddin Raad, Pennell Dudley, Schreiber Benjamin, Prasad Sanjay K
Format:	Article
Language:	English
Published:	BMC 2013-01-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
by: Prasad Sanjay, et al.
Published: (2009-01-01)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
by: Roussin Isabelle, et al.
Published: (2013-01-01)

Cine acquisition strategies for visualizing atrial septal defects by CMR
by: Natarajan Arun, et al.
Published: (2013-01-01)

Cardiac magnetic resonance perfusion imaging and the effects of single intravenous cannulation with the Octopus bionector
by: Kindler Heiko E, et al.
Published: (2013-01-01)

Randomised controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major
by: Arun John Baksi, et al.
Published: (2014-09-01)

Left ventricular function, aortic velocity, and late gadolinium enhancement assessed by real-time and single shot CMR is comparable to breath-held segmented imaging: a prospective study
by: Aneja Ashish, et al.
Published: (2013-01-01)

2039 T2* CMR in hereditary hemochromatosis
by: O'Hanlon Rory, et al.
Published: (2008-10-01)

CMR shows that anthracycline cardiotoxicity is common in women treated for early breast cancer and associated with undiagnosed hypertension; but cannot be reliably detected using late-gadolinium enhancement imaging
by: Kotwinski Paul, et al.
Published: (2013-01-01)

Low diagnostic yield of Late Gadolinium Enhancement (LGE) in screening patients with suspected Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) by Cardiovascular Magnetic Resonance (CMR)
by: van Hoorn Frans, et al.
Published: (2012-02-01)

Moderate to severe renal impairment cannot be reliably detected from medical history alone: Implications for the use of Gadolinium-based contrast agents
by: Burman Elizabeth, et al.
Published: (2009-01-01)

Feasibility of detecting myocardial infarction in the sheep fetus using late gadolinium enhancement CMR imaging
by: An Qi Duan, et al.
Published: (2017-09-01)

2014 Left ventricular ejection function and viability assessed by CMR in patients undergoing anterograde versus retrograde percutaneous coronary interventions for chronic total occlusion: a Ppe and post procedure study
by: Di Mario Carlo, et al.
Published: (2008-10-01)

Prognostic CMR predictors of adverse outcomes in patients with suspected ARVC
by: Deac Monica, et al.
Published: (2010-01-01)

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
by: Ismail Tevfik F, et al.
Published: (2012-02-01)

3D whole-heart phase sensitive inversion recovery CMR for simultaneous black-blood late gadolinium enhancement and bright-blood coronary CMR angiography
by: Giulia Ginami, et al.
Published: (2017-11-01)

The predictive value of normal CMR scans in patients with suspected ARVC - an outcomes study
by: Pennell Dudley J, et al.
Published: (2010-01-01)

Remodeling after acute myocardial infarction: mapping ventricular dilatation using three dimensional CMR image registration
by: O’Regan Declan P, et al.
Published: (2012-06-01)

T2-STIR CMR imaging can be used to assess myocardium at risk with gadolinium present in an experimental setting
by: Nordlund David, et al.
Published: (2013-01-01)

CMR evaluation in patients with high grade ventricular arrhythmias
by: Brisinda Donatella, et al.
Published: (2009-01-01)

Regional assessment of left ventricular torsion by CMR tagging
by: Marcus J Tim, et al.
Published: (2008-05-01)

Late gadolinium enhancement in cardiac sarcoidosis predicts ICD implantation and appropriate discharge
by: Wells Athol, et al.
Published: (2010-01-01)

Beyond late gadolinium enhancement: the key role of diffuse myocardial fibrosis in severe aortic stenosis - an Equilibrium Contrast CMR study
by: Mcgregor Christopher, et al.
Published: (2011-02-01)

A model based on clinical parameters to identify myocardial late gadolinium enhancement by magnetic resonance in patients with aortic stenosis: An observational study
by: Mariya Kuk, et al.
Published: (2020-04-01)

Early infarct size prediction with two-dimensional speckle tracking echocardiography compared with late gadolinium enhanced CMR
by: Ovize Michel, et al.
Published: (2009-01-01)

Free-breathing late gadolinium enhancement CMR with a fixed short scan time using CosMo
by: Moghari Mehdi H, et al.
Published: (2012-02-01)

406 CMR assessment of the mitral valve: technical considerations
by: Kilner Philip J, et al.
Published: (2008-10-01)

Imaging myocardial carcinoid with T2-STIR CMR
by: Baker Christopher, et al.
Published: (2008-03-01)

Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy
by: Pennell Dudley J, et al.
Published: (2011-10-01)

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance
by: Tanner Mark A, et al.
Published: (2011-01-01)

Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016-11-01)

Review of Journal of Cardiovascular Magnetic Resonance 2011
by: Pennell Dudley J, et al.
Published: (2012-11-01)

2070 Mitral valve prolapse is associated with abnormal CMR late gadolinium enhancement of the mitral valve leaflets and the papillary muscles
by: Zimetbaum Peter J, et al.
Published: (2008-10-01)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
by: Marthe A.J. Becker, et al.
Published: (2020-02-01)

Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome
by: Afsharzada Farshid, et al.
Published: (2009-03-01)

Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics
by: Lynne K. Williams, et al.
Published: (2017-08-01)

The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity
by: Kotwinski Paul, et al.
Published: (2013-01-01)

1024 A novel CMR-based myocardial salvage index predicts left ventricular remodeling after acute myocardial infarction: insights from T2-weighted and late gadolinium enhancement imaging
by: Schulz-Menger Jeanette, et al.
Published: (2008-10-01)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

Relationship between CMR and ECG-derived indices of left ventricular hypertrophy
by: Alder Nicola, et al.
Published: (2009-01-01)

Feasibility of quantitative perfusion CMR in patients with poor left ventricular function
by: Sammut Eva, et al.
Published: (2013-01-01)